Wei Kang

7PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 10, 2026
Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis : A Target Trial Emulation.

|Jan 30, 2026
Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An Evaluation.

Wei Kang, Chin-Yao Shen, Michael Chun-Yuan Cheng

|Jul 19, 2024
Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis.

Wei Kang, Kuan Peng, Vincent K C Yan

|Jul 05, 2024
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis.

Wei Kang, Caige Huang, Vincent K C Yan

|Apr 29, 2023
BNT162b2 or CoronaVac Vaccinations Are Associated With a Lower Risk of Myocardial Infarction and Stroke After SARS-CoV-2 Infection Among Patients With Cardiovascular Disease.

Xuxiao Ye, Vincent K C Yan, Hei Hang Edmund Yiu

|Jun 22, 2022
Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease.

Xuxiao Ye, Tiantian Ma, Joseph E Blais

Pageof 2

Frequent Collaborators

7 joint publications

Esther W Y Chan

7 joint publications

Vincent K C Yan

6 joint publications

Ian Chi Kei Wong

4 joint publications

Xuxiao Ye